Level C· Early human research exploring benefitsProspective StudyPubMed

Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury.

Chien MH., Bien MY., Ku CC., Chang YC., Pao HY., Yang YL.

Prospective Study on Chronic Inflammation, published in Crit Care Med (2012) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Crit Care Med (2012)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
22202710
DOI
10.1097/CCM.0b013e31823bc89a

Abstract (original English)

Acute lung injury results in acute respiratory distress syndrome. There is no standard therapy for acute respiratory distress syndrome but supportive care. Stem cells offer a new therapeutic potential for tissue regeneration as a result of their self-renewal, multipotency, and paracrine capabilities. The objective of this study is to investigate the effects and the mechanisms of systemic human orbital fat-derived stem/stromal cell transplantation on lipopolysaccharide-induced acute lung injury. Prospective, randomized, controlled study. University-affiliated research institute. Male BALB/c mice. Twenty-five micrograms lipopolysaccharide in 50 μL sterile saline or 50 μL of sterile saline was delivered through intratracheal injection. Twenty mins later, the animals were further randomized into subgroups that received either a tail vein injection of 3 × 10 orbital fat-derived stem/stromal cells in 50 μL phosphate-buffered saline or 50 μL phosphate-buffered saline. Low immunogenicity and immune-tolerated of orbital fat-derived stem/stromal cells were observed in this xenotransplanted model. Orbital fat-derived stem/stromal cells significantly reduced lipopolysaccharide-induced pulmonary inflammation, which was evidenced by a decrease in total protein concentration and neutrophil counts in alveolar fluid through bronchoalveolar lavage, reduced endothelial and alveolar epithelial per

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Acute Lung InjuryAdipose TissueAnimalsCytokinesHumansLipopolysaccharidesLungMaleMiceMice, Inbred BALB C

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research